Suppression of in vitro lymphocyte reactivity to phytohemagglutinin by placental protein 14.
Crude human decidual extracts containing up to 26.6 mg/l of placental protein 14 (PP14) and purified PP14 were assessed for their effects on the in vitro lymphocyte reactivity to phytohemagglutinin (PHA). Both decidual extract and purified PP14 suppressed the mitogenic response to PHA with the suppression being dose-dependent over the range of PP14 concentrations investigated (0-26.6 mg/l). On the specific reduction of the PP14 content by a monoclonal anti-PP14 immunoadsorbant the suppression was reduced. The suppressive activity of PP14 was related to the degree of proliferation of the stimulated lymphocytes. These results suggest that PP14, which is present at peak levels in the first trimester of pregnancy and constitutes up to 10% of the soluble protein content of decidual tissue, may be an immunomodulator important for the survival of the implanting embryo and maintenance of early pregnancy.
Department of Biological Sciences, Sheffield City Polytechnic, U.K.
A G
AG
Pockley
E A
EA
Mowles
R J
RJ
Stoker
O M
OM
Westwood
M G
MG
Chapman
A E
AE
Bolton
D003656:Decidua / Q000276:immunology; D005260:Female; D000071816:Glycodelin; D006023:Glycoproteins; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D010835:Phytohemagglutinins / Q000494:pharmacology; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000276:immunology / Q000302:isolation & purification / Q000494:pharmacology*; D013491:Suppressor Factors, Immunologic
D000071816:Glycodelin; D006023:Glycoproteins; C045246:PAEP protein, human; D010835:Phytohemagglutinins; D011257:Pregnancy Proteins; D013491:Suppressor Factors, Immunologic